本司产品仅用于科研,不用于临床诊断和治疗

当前位置:首页 >> 技术支持 当前位置:首页 >> 技术支持 >> 文献应用

普诺赛致力于为科研客户提供高品质的细胞及培养相关产品,产品范围涵盖原代细胞、细胞系、胎牛血清,完全培养基,及其他培养试剂。经过多年的坚持和努力,普诺赛已协助客户发表高分文献4000余篇,文献常见于Nature Biotechnology、Nature Nanotechnology、Advanced Materials、Materials Today等行业顶尖期刊。

点击申请文献奖励

  • Palmitoylation of PKCδ by ZDHHC5 in hypothalamic microglia presents as a therapeutic target for fatty liver disease (2024/01/01)
    IF: 12.400
    作者:Yanhang Wang, Xin Chen, Yizhen Bai
    期刊: Theranostics
    DOI:10.7150/thno.89602
    引用产品: PM150110  
  • Exogenous antibiotic resistance gene contributes to intestinal inflammation by modulating the gut microbiome and inflammatory cytokine responses in mouse (2022/12/27)
    IF: 12.200
    作者:Rong Tan, Min Jin, Zhengshan Chen
    期刊: Gut Microbes
    DOI:10.1080/19490976.2022.2156764
    引用产品: PM150110  
  • The alternation of halobenzoquinone disinfection byproduct on toxicogenomics of DNA damage and repair in uroepithelial cells (2023/12/22)
    IF: 11.800
    作者:Xu Zhang, Lifang Liu, Jun Wang
    期刊: ENVIRONMENT INTERNATIONAL
    DOI:10.1016/j.envint.2023.108407
    引用产品: PM150810  
  • Neonicotinoid insecticides promote breast cancer progression via G protein-coupled estrogen receptor: In vivo, in vitro and in silico studies (2022/10/06)
    IF: 11.800
    作者:Xin Li, Sen He, Han Xiao
    期刊: ENVIRONMENT INTERNATIONAL
    DOI:10.1016/j.envint.2022.107568
    引用产品: CL-0007   PB180120   PM150110   PM150120  
  • ZDHHC2-mediated AGK palmitoylation activates AKT/mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma (2023/04/20)
    IF: 11.500
    作者:Yan Sun, Liang Zhu, Pian Liu
    期刊: CANCER RESEARCH
    DOI:10.1158/0008-5472.CAN-22-3105
    引用产品: CL-0254   P-CA-101   PM150410  
  • A novel CPT1A covalent inhibitor modulates fatty acid oxidation and CPT1A-VDAC1 axis with therapeutic potential for colorectal cancer (2023/11/10)
    IF: 11.400
    作者:Anni Hu, Hang Wang, Qianqian Xu
    期刊: Redox Biology
    DOI:10.1016/j.redox.2023.102959
    引用产品: PM150210  
  • Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer (2024/02/26)
    IF: 11.300
    作者:Weisong Li, Kai Zhang, Wenjun Wang
    期刊: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    DOI:10.1186/s13046-024-02981-5
    引用产品: PM150710  
  • EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance (2024/01/02)
    IF: 11.300
    作者:Wenjie Wei, Kan Liu, Xing Huang
    期刊: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    DOI:10.1186/s13046-023-02932-6
    引用产品: PM150210  
首页 上一页 3456789101112 下一页 末页 合计150页 合计1199条记录
×